World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
76
Citations
34654
World Ranking
18615
National Ranking
620

Overview

Josy Reiffers is affiliated with the Centre national de la recherche scientifique (CNRS) in France. Their work is linked to this prominent French research institution, which supports a wide range of scientific disciplines across multiple fields of study.

Although there is no detailed listing of Josy Reiffers' publications or frequent co-authors available, their connection with CNRS suggests involvement in rigorous academic research and collaboration within the scientific community.

The profile does not provide specific data on the main fields of study, subfields, or primary research topics associated with Josy Reiffers. Similarly, information on recent papers, book publications, or frequent publication venues has not been disclosed.

No awards or honors are recorded for Josy Reiffers in the provided data, and there is no indication that the scientist is deceased.

Best Publications

  • Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

    Stephen G. O'Brien;François Guilhot;Richard A. Larson;Insa Gathmann

  • Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

    Brian J. Druker;François Guilhot;Stephen G. O'brien;Insa Gathmann

  • Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial

    François-Xavier Mahon;Delphine Réa;Joëlle Guilhot;François Guilhot

  • Noninvasive Ventilation in Immunosuppressed Patients with Pulmonary Infiltrates, Fever, and Acute Respiratory Failure

    Gilles Hilbert;Didier Gruson;Fréderic Vargas;Ruddy Valentino

  • Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance

    François Xavier Mahon;Michael W. N. Deininger;Beate Schultheis;Jérome Chabrol

  • MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models.

    François-Xavier Mahon;Francis Belloc;Valérie Lagarde;Claudine Chollet

  • Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia

    Stephane Picard;Karine Titier;Gabriel Etienne;Emmanuelle Teilhet

  • Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years

    Philippe Rousselot;Francoise Huguet;Delphine Rea;Laurence Legros

  • Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib

    Carlo Gambacorti-Passerini;Laura Antolini;Franois Xavier Mahon;Francois Guilhot

  • Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib After Durable Undetectable Disease

    Philippe Rousselot;Aude Charbonnier;Pascale Cony-Makhoul;Philippe Agape

  • Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres.

    G. Gahrton;H. Svensson;M. Cavo;J. Apperley

  • A Controlled Study of Recombinant Human Granulocyte Colony-Stimulating Factor in Elderly Patients after Treatment for Acute Myelogenous Leukemia

    Hervé Dombret;Claude Chastang;Pierre Fenaux;Josy Reiffers

  • Allogeneic bone marrow transplantation in multiple myeloma

    G Gahrton;S Tura;P Ljungman;C Belanger

  • Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders

    Francesca Bonifazi;Antonio de Vivo;Gianantonio Rosti;François Guilhot

  • Allogeneic bone marrow transplantation for acute myeloid leukemia in first remission: a randomized trial of a busulfan-Cytoxan versus Cytoxan-total body irradiation as preparative regimen: a report from the Group d'Etudes de la Greffe de Moelle Osseuse.

    D Blaise;D Maraninchi;E Archimbaud;J Reiffers

  • Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia

    F Lacombe;F Durrieu;A Briais;P Dumain

  • Allogeneic bone marrow transplantation for children with acute myeloblastic leukemia in first complete remission: impact of conditioning regimen without total-body irradiation--a report from the Société Française de Greffe de Moelle.

    G Michel;G Socié;F Gebhard;F Bernaudin

  • Multidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia

    Stéphanie Dulucq;Stéphane Bouchet;Béatrice Turcq;Eric Lippert

  • Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia.

    Reiffers J;Bernard P;David B;Vezon G

  • Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia.

    C Sebban;E Lepage;J P Vernant;E Gluckman

Frequent Co-Authors

Mauricette Michallet
Mauricette Michallet University of Helsinki
Francois Guilhot
Francois Guilhot Grenoble Alpes University
Eliane Gluckman
Eliane Gluckman Université Paris Cité
Norbert Ifrah
Norbert Ifrah Grenoble Alpes University
Michel Attal
Michel Attal Janssen (Belgium)
Pierre Bordigoni
Pierre Bordigoni Boston Children's Hospital
Myriam Labopin
Myriam Labopin Université Paris Cité
Gérard Socié
Gérard Socié Université Paris Cité
Richard A. Larson
Richard A. Larson University of Chicago
Daniel Olive
Daniel Olive Aix-Marseille University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens the door to a diverse range of educational pathways beyond the traditional MD track. Many students consider healthcare management roles, and pursuing the best online healthcare administration degree can be a fast and flexible choice. These programs are ideal for those interested in leading healthcare organizations or managing hospital operations.

For registered nurses seeking advanced clinical roles, asn to np programs provide an efficient bridge from an associate degree to a nurse practitioner qualification. These bridge programs often cater to working professionals and are available in online formats for added convenience.

Nutrition is another popular and growing field. Students committed to promoting wellness and disease prevention may benefit from pursuing online degrees in nutrition. Such degrees can lead to careers as dietitians, nutritionists, and health educators.

Those aiming for upper-level positions in healthcare administration can look for cahme accredited master’s programs, which set the national standard for healthcare management education.

Best Scientists Citing Josy Reiffers

Recently Published Articles